REG - Partners Grp Pvt Eqt Partners Grp E-PEYS - PGPE Ltd publishes August NAV

Partners Private EquityAnnouncement

03/10/2025 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251003:nRSC9807Ba&default-theme=true

RNS Number : 9807B  Partners Group Private Equity Ltd  03 October 2025

(LSE: PEY/PEYS)

 

Partners Group Private Equity Limited

 

NAV declined by 0.7% in August

 

 

·    NAV decreased to EUR 13.80 per share, corresponding to EUR 954.1
million

·    Value creation (+0.7%) offset by unfavorable currency movements
(-1.0%)

·    PGPE Ltd received EUR 14.2 million in distributions and invested EUR
3.2 million during the month

 

The NAV of PGPE Ltd closed in August at EUR 13.80 per share. The underlying
portfolio delivered solid value creation of 0.7%, though this was offset by
currency headwinds primarily as the US Dollar weakened 2.2% against the Euro
during the month, negatively impacting NAV by 1.0% and resulting in a total
return decline of 0.7%

 

Over the same period, PGPE Ltd received EUR 14.2 million in distributions, of
which EUR 9.3 million stemmed from the exit of its investment in Global Blue,
a provider of VAT refund and foreign exchange services for international
travelers. In February this year, the company announced that it had entered
into a definitive agreement under which Shift4, an integrated payments and
commerce technology provider, would acquire the business in an all-cash
transaction, valued at approximately USD 2.5 billion (enterprise value). The
transaction was finalized recently. Following the acquisition, Global Blue
will be delisted from the NYSE. Partners Group, on behalf of its clients,
originally invested in Global Blue in 2012 and listed the company on the NYSE
in 2020, subsequently selling down a portion of its holding.

 

EUR 4.5 million came from a further sale of shares of Galderma, a pure-play
dermatology category leader. As of 31 August 2025, the remaining NAV of
Galderma in the portfolio of PGPE Ltd is EUR 23.8 million. Recently, Galderma
released its financial report for the first half of 2025, which showed record
net sales of over USD 2 billion and 12.2% year-on-year growth on constant
currency terms. This was driven by volume growth and a favorable change in
sales mix. Meanwhile, new product launches showed significant progress.

 

Finally, PGPE Ltd invested EUR 1.6 million in restor3d, a technology-driven
orthopedic solutions specialist in the US. Founded in 2017, restor3d offers a
full portfolio of implants across shoulder, hip, knee, foot, and ankle, and
combines proprietary AI-driven design software, vertically integrated
manufacturing, and rapid surgical planning. In 2024, restor3d partnered with
more than 520 surgeons across 740 hospitals nationwide.

 

Ends.

 

About Partners Group Private Equity Limited

PGPE Ltd is an investment holding company founded in 1999 and domiciled in
Guernsey. It invests in private equity direct investments. PGPE Ltd is managed
in its investment activities by Partners Group, a global private markets
investment management firm with over USD 174 billion in investment programs
under management in private markets, of which USD 83 billion is in private
equity. Partners Group itself is listed on the Swiss Stock Exchange (ticker:
PGHN). PGPE Ltd aims to provide shareholders with long-term capital growth and
an attractive dividend yield. PGPE Ltd is traded on the Main Market of the
London Stock Exchange (ticker: PEY for the Euro quote; PEYS for the Sterling
quote).

 

 

Contacts

Partners Group Private Equity Limited:

pgpe-ltd@partnersgroup.com

www.partnersgroupprivateequitylimited.com

 

 Investor relations contact:                  Media relations contact:

 Andreea Mateescu                             Jenny Blinch

 Phone: +41 41 784 66 73                      Phone: +41 41 784 65 26

 E-mail: andreea.mateescu@partnersgroup.com   E-mail: jenny.blinch@partnersgroup.com

 

Registered Number: 35241   LEI: 54930038LU8RDPFFVJ57

Notes:

1.     Note that references in this announcement to Partners Group Private
Equity Limited have been abbreviated to "PGPE Ltd" or "the Company".
References to Partners Group AG have been abbreviated to "Partners Group" or
"the Investment Manager".

2.     This document does not constitute an offer to sell or a
solicitation of an offer to buy or subscribe for any securities and neither is
it intended to be an investment advertisement or sales instrument of Partners
Group Private Equity Limited. The distribution of this document may be
restricted by law in certain jurisdictions. Persons into whose possession this
document comes must inform themselves about and observe any such restrictions
on the distribution of this document. In particular, this document and the
information contained therein are not for distribution or publication, neither
directly nor indirectly, in or into the United States of America, Canada,
Australia or Japan.

3.     This document may have been prepared using financial information
contained in the books and records of the product described herein as of the
reporting date. This information is believed to be accurate but has not been
audited by any third party. This document may describe past performance, which
may not be indicative of future results. No liability is accepted for any
actions taken on the basis of the information provided in this document.
Neither the contents of PGPE Ltd's website nor the contents of any website
accessible from hyperlinks on PGPE Ltd's website (or any other website) are
incorporated into, or form part of, this announcement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCPKNBPNBDKPKK